As PEDF possesses strong antiangiogenic properties, its examination in conjunction with the chemotherapeutic doxorubicin, when applied to a chemoresistant osteosarcoma tumour, enhances the tumour’s responsiveness to treatment [116,117]. The gene discussed is SERPINF1; the disease is osteosarcoma.